Peer Review History
| Original SubmissionSeptember 29, 2021 |
|---|
|
PONE-D-21-30893 The effectiveness of a web-based Dutch parenting program to prevent overweight in children 9-13 years of age: results of a two-armed cluster randomized controlled trial PLOS ONE Dear Dr. Ruiter, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The decision for this paper is a difficult one. Let me start by saying that I believe it is important to publish this paper, its just a difficult situation. On the one hand you have taken the appropriate steps, registering the clinical trial, publishing a study protocol, and then for the most part following that protocol in this paper. On the other hand, I have many of the same concerns that are raised by the statistical reviewer as well as a few others. I think you should know where I’m coming from as an editor, while I’m trained as a social scientist, my primary role is as a methodologist, I’ve been the primary statistical methods person on multiple randomized and group randomized trials, some targeting physical activity and weight loss. I am also a reviewer for major clinical trials grants in the area. If I had reviewed either the grant application or the study protocol paper I would have had reservations about the statistical methods proposed (doing analyses in Mplus with TYPE = COMPLEX, failure to account for multiple testing, dichotomizing outcomes, treating T1 and T2 as separate outcomes, reporting both ITT and completers only analysis) and would have requested major revisions. So, now the question I’m facing is how to reconcile the desire to stay true to the published protocol paper versus moving forward with results that do not meet the standard I would expect from a clinical trial. My overall decision at this point is to request major revisions which try to address these issues. I’ll also note that I held off sending this paper out to content specific reviewers because I wanted to see if the statistics reviewer had the same concerns I did, and because the substantive reviews will likely be better if these other issues are fixed. Several things seem straight forward to me: 1) the protocol paper did not include per-protocol analyses, I believe that these need to be dropped or if they are retained they need to be done using Complier Average Causal Effects analyses appropriate for cluster randomized trials (there is a paper out there on doing this by Booil Jo), but these are difficult analyses to do and I would want the code and output included so that they could be checked; 2) the protocol paper did not mention how multiple outcomes would be tested, this is really a major problem, you have 13 outcomes multiplied by two different reporters (parents and children) and two different time points, so 52 different analyses for 3 different types of analyses. The trial registration includes 7 primary outcomes, only a little bit better. This needs to be addressed and I’m not sure that you have many options at this point, but the end result is likely that there are no reliable differences between treatment and control groups; 3) Your actual statistical analyses need to be made clear. You simply report that you used Mplus with type=complex, this is not the statistical analysis, it is just the software used. As the statistical reviewer mentions, the models used need to be reported in careful detail with all predictors and outcomes specified, assumptions tested, and variance components reported; 4) the justification for the sample size calculations needs to be made in much more detail including both the ICC assumptions and the effect size assumptions along with references; 5) Missing data and imputation needs to be described in more detail. Now the difficult things. First of all is your use of Mplus and type=complex to account for the clustering in the data. I’m going to start by nothing that you are wrong about this being multilevel analysis, when you use the type=complex option Mplus simply adjusts the standard errors of your effects for clustering using a sandwich estimator, but this is not a multilevel regression model. The first reason I don’t typically suggest Mplus for multilevel models is that users often don’t understand what is happening, the second is that many Mplus features are not well documented and it really isn’t clear what sandwich estimator is employed. In any case, this should be similar to more typical implementations of GEE. While GEE can be acceptable in GRTs for correcting for clustering, it isn’t very efficient and the approach recommended by the reviewer is clearly the standard. A recent paper by Turner et al (American J of Public Health) discusses some of these issues. If the protocol paper wasn’t published I would feel quite strongly (along with the stats reviewer) that the current analyses should be completely replaced with the conventional multilevel models recommended by the reviewer. However, given the existence of the protocol paper, my suggestion is that the ITT and completers analyses stays as is (with the full model including all covariates and variance parameter estimates described) but that the analyses suggested by the reviewer be included in an appendix and any discrepancies noted. There really shouldn’t be large discrepancies if everything was done right, and my reason for asking for this is that it will greatly increase my confidence that everything was done right. Second, were covariates included in these analyses? Also, was the analyses the outcome at time T controlling for baseline or was it change scores? If covariates were not included, why not? I agree with the reviewer that baseline values for weight as other variables should have been included, the protocol paper is not clear about how or if this will be done. Third, I’m not sure that all of your effect sizes are even in the correct direction for the few significant treatment effects. Looks like there were more sweetened beverages consumed in the treatment than control groups? Also, some of the significance tests in the completers only table seem to be off? Oh, the use of superscripts to indicate which effects are significant for which set of analyses doesn’t work at all. You should probably just report the full results of the ITT and then, separately, of the completers-only analyses (again, dropping the protocol analyses). I’ve noted several other issues. One is that I doubt that substantive reviewers would be impressed with your outcomes for the dietary or physical activity measures. On the trials I’ve been on we have ignored self or parent reported PA and focused exclusively on accelerometer measured PA because of concerns about bias as well as unreliability. Obviously you can’t change this now, but it needs to be a very important discussion point and the issues with the measures need to be made very clear. Another issue which is really major is that I do not think you have interpreted these results correctly. You conclude that, “our web-based parenting program yields promising effects…” and when I look at your results the ITT analyses (these should be the gold standard) truly show no effects if you do any meaningful correction for multiple comparisons. Again, it looks to me like some of your results are in the wrong direction which also suggests no overall effects. The completers only analyses looks about the same to me. My best guess looking at these results is that this study has more evidence of no effects than of effects, the only place where you see something is the per-protocol analyses but those results are well known to be biased the way you did them. My final note is that I disagree with the reviewer about dropping the tables with parameter estimates and standard errors, I would focus more rather than less on them. Please submit your revised manuscript by Dec 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Lee Van Horn, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 3. Please provide the original, full-length study protocol, or project proposal, that you submitted to your ethics committee for review and approval prior to study commencement. This document should typically contain a background section, detailed description of the methods used (including information about dates of recruitment, participant characteristics, inclusion/exclusion criteria, detailed descriptions of the protocols/interventions utilized, plans for outcome assessment and data collection/analysis, and references). Please note that we require this to be submitted with your manuscript in both the original language version and a version translated into English. 4. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study. As per the journal’s editorial policy, please include in the Methods section of your paper: a) your reasons for your delay in registering this study (after enrolment of participants started); b) confirmation that all related trials are registered by stating: “The authors confirm that all ongoing and related trials for this drug/intervention are registered 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This study was funded by a grant from the Netherlands Organization for Health Research and Development (ZonMw; project number 505010296015), which played no role in the design of execution of this study, the analysis or interpretation of the data, or the decision to publish the results." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This study was funded by a grant from the Netherlands Organization for Health Research and Development (ZonMw; project number 505010296015, 200100001). This funder had no role in study design, data collection and analysis, interpretation of the data, decision to publish the results, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Sample size: why the intra class correlation is set at a low level of 0.05? Missing data: what method was used for imputation? There are discrepancies between ITT and per-protocol analysis. It is better to try different method of imputation and evaluate the consistency. Did you consider Race and overweight which are significantly correlated with loss to follow-up? Data analysis: Not sure what “multilevel multiple regression” is. It seems that it is better to use generalized linear mixed models (GLMM) for the clustered and repeated dichotomous measure. In the GLMM, the random cluster and time should be tested for significant. The time * intervention interaction should also be tested. What baseline characteristics were adjusted in the model? How did you adjust for Race and overweight which are significantly correlated with loss to follow-up? This needs careful consideration and discussion. If multiple children in the same family were recruited, was the correlation within the same family adjusted in your model? For so many outcomes, p values need to be adjusted for multiple tests. Results: Table 1: separate overweight and obesity Table 3 can be omitted. Add the p values to Table 4. Similarly, for table 5 report OR, 95% CI and p values. Do not report regression coefficients. Add p values to Table 6. Needs more consideration and discussion about the discrepancies between ITT and per-protocol results. 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-30893R1The effectiveness of a web-based Dutch parenting program to prevent overweight in children 9-13 years of age: results of a two-armed cluster randomized controlled trialPLOS ONE Dear Dr. Ruiter, Thank you for resubmitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ==============================I have now obtained a second review from the original stats reviewer, a new review from an expert in this content area, and have reviewed the manuscript again myself. The new reviewer has raised a number of issues which should be addressed. My impression is that these can be done fairly quickly and I will do my best to make a decision quickly in the next round based on your response to these reviews. ============================== Please submit your revised manuscript by Jul 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Lee Van Horn, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Thank you for the opportunity to review a revised version of the manuscript, “The effectiveness of a web-based Dutch parenting program to prevent overweight in children 9-13 years of age: results of a two-armed cluster randomized controlled trial.” This paper presents the results of a cluster-randomized trial conducted in the Netherlands of a web-based parenting program known as “Making a healthy deal with your child.” The intervention consisted of five 30-minute modules that walked parents through challenging parenting situations specific to youth’s healthy lifestyle behaviors (e.g., struggles with child consuming vegetables, having excess screen time). While involving parents in childhood obesity-related interventions is the gold standard for treatment, school-based approaches are more common for prevention, with parent involvement and participation generally being more variable in these interventions. In this study, authors ask an important research question in that they aim to assess the value of adding an online self-guided parenting component to an existing school-based intervention, “Scoring for Health.” From my perspective, the authors were quite responsive to the comments of the Editor and statistical reviewer; I defer to them on the need for authors to make further analysis-related revisions. The authors report on a large clinical trial that was registered and for which a protocol paper has been previously published. Further, authors describe the theoretical underpinnings of the program as coming from strong evidence-based positive parenting programs – parent effectiveness training and the Parent Management Training – Oregon Model. The authors report that they developed the intervention with qualitative input from mothers who lived in low-SES neighborhoods. The study team collected data at three time points, and participant retention rates were good, with 72% completing the 12-month follow up assessment. Authors also reported process evaluation data related to parents’ use of the intervention (e.g., log-in activity, module completion). My concerns include the use of a within-school rather than between-school design due to contamination effects as well as the exclusive use of self-reported measures to assess study outcomes (though the authors do mention both of these in their limitations section). Overall, I think this manuscript will add to the ongoing conversation in the literature about ways to involve parents in obesity prevention efforts using digital approaches. My specific recommendations regarding each section of the paper are detailed below. I hope the authors find these comments useful as they continue to move this work forward. Abstract: • Minor - The abstract entered in the manuscript submission portal does not match the abstract in the revised version of the manuscript. Introduction: • I encourage the authors to use people-first language when referring to children with overweight or obesity in the introduction and throughout the manuscript. Information and examples of people-first language specific to obesity may be found here: https://www.obesityaction.org/action-through-advocacy/weight-bias/people-first-language/ For example, rather than using the term “obese children,” use “children with obesity.” • Authors may want to cite some more up-to-date review papers when discussing the role of parents in obesity prevention and treatment more broadly: o St. George et al. (2020). A developmental cascade perspective of paediatric obesity: A systematic review of preventive interventions from infancy through late adolescence. Obesity Reviews, 21(2), e12939. o Tomayko et al. (2021). Parent involvement in diet or physical activity interventions to treat or prevent childhood obesity: An umbrella review. Nutrients, 13(9), 3227. And importantly, include a bit more in the way of parent involvement in digital lifestyle interventions: o Hammersley ML, Jones RA, Okely AD. Parent-focused childhood and adolescent overweight and obesity eHealth interventions: a systematic review and meta-analysis. Journal of Medical Internet Research. 2016;18(7):e5893. o Kemp BJ, Thompson DR, Watson CJ, McGuigan K, Woodside JV, Ski CF. Effectiveness of family-based eHealth interventions in cardiovascular disease risk reduction: A systematic review. Preventive Medicine. 2021:106608. • The authors do a nice job distinguising general positive parenting practices from domain-specific positive parenting practices and their relevance to childhood obesity (there is helpful discussion on the distinction between these in a paper by Power, Sleddens, and colleagues (2013) published in Childhood Obesity – Contemporary research on parenting: Conceptual, methodological, and translational issues). However, it is not clear from the hypotheses on page 7 what specific EBRB parenting practices they will examine as secondary outcomes. Please list them here. Minor: • Remove the word “becoming” from the first sentence of the paper. Overweight and obesity in children is a major health concern. • Missing the word “time” in the following sentence on page 6: “v) children spending an excessive amount of [time] using the computer and not wanting …” Methods and Results: These sections seem to have greatly benefitted from responding to the suggestions of the Editor and statistical reviewer. I have only a few questions/comments: 1. It appears as though parents assigned to the intervention condition received an email up front with their log-in code/access to the modules and then a congratulatory email following the completion of each module. I was less clear as to whether there were any automated reminder emails or any follow-up from study staff encouraging parents to complete the modules --- this information is included in the discussion but might be helpful to note in the methods section. 2. Authors currently present process data as parents who completed one module or 2 or more modules. How many parents completed 3, 4, and 5 modules? I was interested in more granular details regarding module completion as I believe this may have important implications for understanding study findings. 3. It’s interesting that measures of height were taken using a tape measure rather than a stadiometer. Why was this instrument selected to assess height (maybe ease of transporting)? 4. Where the response options for the parental EBRB rules measure (i.e., strict, indulgent, no rules) part of the original measure or did the authors develop these for the current study? I wondered why an option around the presence of rules that were reasonable (somewhere in between strict and indulgent) was not included. Discussion: • Authors note “our findings indicate that the program has room for improvement, as the intervention was not used intensively enough.” I think this point may be understated and that authors could discuss the issue of dose received in more detail earlier in the discussion rather than waiting until the strengths/limitations section. It is difficult to ascertain whether or not the intervention ‘worked’ when uptake was low. • Related to my comment above, engagement in eHealth interventions is arguably one of the biggest challenges in the field. To what extent did authors include their target population in the process of developing their intervention modules? Did authors follow up with families to understand reasons they did or did not view the modules? They speculate that participants may not have been the appropriate targets and that a higher risk group may have been more appropriate, which is a fair point, but other strategies for increasing engagement beyond email reminders may have been helpful. For example, Mohr and colleagues have argued that supportive accountability via human contact may be required to get participants to engage with digital interventions. See: Mohr et al. (2011). Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. Journal of Medical Internet Research, 13(1), e30) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The effectiveness of a web-based Dutch parenting program to prevent overweight in children 9-13 years of age: results of a two-armed cluster randomized controlled trial PONE-D-21-30893R2 Dear Dr. Ruiter, Thank you for the work you put into revising this paper. After carefully reading the revisions, your response, and the previous reviews I've decided that this version adequately addresses the concerns and am am pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Lee Van Horn, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-30893R2 The effectiveness of a web-based Dutch parenting program to prevent overweight in children 9-13 years of age: results of a two-armed cluster randomized controlled trial Dear Dr. Ruiter: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Lee Van Horn Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .